17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Sundriyal S, Chen PB, Lubin AS, Lueg GA, Li F, White AJP, Malmquist NA, Vedadi M, Scherf A, Fuchter MJ. Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity. Medchemcomm. 8: 1069-1092. PMID 29308121 DOI: 10.1039/C7Md00052A  0.355
2017 Sundriyal S, Moniot S, Mahmud Z, Yao S, Di Fruscia P, Reynolds CR, Dexter DT, Sternberg MJ, Lam EW, Steegborn C, Fuchter MJ. Thienopyrimidinone based sirtuin-2 (SIRT2)-selective inhibitors bind in the ligand induced 'selectivity pocket'. Journal of Medicinal Chemistry. PMID 28135086 DOI: 10.1021/Acs.Jmedchem.6B01690  0.344
2015 Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, Suwanarusk R, Renia L, Nosten F, Jiménez-Díaz MB, Angulo-Barturen I, Santos Martínez M, Ferrer S, Sanz LM, Gamo FJ, et al. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans. Antimicrobial Agents and Chemotherapy. 59: 950-9. PMID 25421480 DOI: 10.1128/Aac.04419-14  0.306
2014 Srimongkolpithak N, Sundriyal S, Li F, Vedadi M, Fuchter MJ. Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4md00274a. Medchemcomm. 5: 1821-1828. PMID 25750706 DOI: 10.1039/C4Md00274A  0.311
2014 Sundriyal S, Malmquist NA, Caron J, Blundell S, Liu F, Chen X, Srimongkolpithak N, Jin J, Charman SA, Scherf A, Fuchter MJ. Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds. Chemmedchem. 9: 2360-73. PMID 25044750 DOI: 10.1002/Cmdc.201402098  0.35
2011 Nair SC, Brooks CF, Goodman CD, Sturm A, Strurm A, McFadden GI, Sundriyal S, Anglin JL, Song Y, Moreno SN, Striepen B. Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. The Journal of Experimental Medicine. 208: 1547-59. PMID 21690250 DOI: 10.1084/Jem.20110039  0.313
2010 Kasetti Y, Patel NK, Sundriyal S, Bharatam PV. Conformational polymorphism in sulfonylurea drugs: electronic structure analysis. The Journal of Physical Chemistry. B. 114: 11603-11. PMID 20718444 DOI: 10.1021/Jp101327K  0.661
2010 Kasetti Y, Patel NK, Sundriyal S, Bharatam PV. Conformational polymorphism in sulfonylurea drugs: Electronic structure analysis Journal of Physical Chemistry B. 114: 11603-11611. DOI: 10.1021/jp101327k  0.668
2010 Sundriyal S, Viswanad B, Ramarao P, Chakraborti AK, Bharatam PV. Corrigendum to “New PPARγ ligands based on barbituric acid: Virtual screening, synthesis and receptor binding studies” [Bioorg. Med. Chem. Lett. 18 (2008) 4959] Bioorganic & Medicinal Chemistry Letters. 20: 424. DOI: 10.1016/J.Bmcl.2009.11.002  0.498
2009 Deng L, Sundriyal S, Rubio V, Shi ZZ, Song Y. Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Journal of Medicinal Chemistry. 52: 6539-42. PMID 19888756 DOI: 10.1021/Jm9012592  0.321
2009 Sundriyal S, Bharatam PV. Important pharmacophoric features of pan PPAR agonists: common chemical feature analysis and virtual screening. European Journal of Medicinal Chemistry. 44: 3488-95. PMID 19268404 DOI: 10.1016/J.Ejmech.2009.01.024  0.318
2008 Sundriyal S, Viswanad B, Ramarao P, Chakraborti AK, Bharatam PV. New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies. Bioorganic & Medicinal Chemistry Letters. 18: 4959-62. PMID 18752947 DOI: 10.1016/J.Bmcl.2008.08.028  0.54
2008 Sundriyal S, Viswanad B, Bharathy E, Ramarao P, Chakraborti AK, Bharatam PV. New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies. Bioorganic & Medicinal Chemistry Letters. 18: 3192-5. PMID 18482837 DOI: 10.1016/J.Bmcl.2008.04.072  0.541
2008 Bharatam PV, Patel DS, Adane L, Mittal A, Sundriyal S. Modeling and informatics in designing anti-diabetic agents. Current Pharmaceutical Design. 13: 3518-30. PMID 18220788 DOI: 10.2174/138161207782794239  0.317
2008 Sundriyal S, Khanna S, Saha R, Bharatam PV. Metformin and glitazones: does similarity in biomolecular mechanism originate from tautomerism in these drugs? Journal of Physical Organic Chemistry. 21: 30-33. DOI: 10.1002/Poc.1273  0.638
2006 Bharatam PV, Sundriyal S. Molecular electrostatic potentials in the design of dendrimers for the delivery of glitazones. Journal of Nanoscience and Nanotechnology. 6: 3277-82. PMID 17048547 DOI: 10.1166/Jnn.2006.473  0.427
2006 Sundriyal S, Sharma RK, Jain R. Current advances in antifungal targets and drug development. Current Medicinal Chemistry. 13: 1321-35. PMID 16712473 DOI: 10.2174/092986706776873023  0.312
Show low-probability matches.